188 related articles for article (PubMed ID: 24115593)
1. p38 Signaling in titanium particle-induced MMP-2 secretion and activation in differentiating MC3T3-E1 cells.
Chen M; Chen PM; Dong QR; Huang Q; She C; Xu W
J Biomed Mater Res A; 2014 Aug; 102(8):2824-32. PubMed ID: 24115593
[TBL] [Abstract][Full Text] [Related]
2. IL-1α induces apoptosis and inhibits the osteoblast differentiation of MC3T3-E1 cells through the JNK and p38 MAPK pathways.
Guo C; Yang XG; Wang F; Ma XY
Int J Mol Med; 2016 Jul; 38(1):319-27. PubMed ID: 27220839
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of p38 mitogen-activated protein kinase down-regulates the inflammatory osteolysis response to titanium particles in a murine osteolysis model.
Chen D; Guo Y; Mao X; Zhang X
Inflammation; 2012 Dec; 35(6):1798-806. PubMed ID: 22763772
[TBL] [Abstract][Full Text] [Related]
4. Polymethylmethacrylate particle exposure causes changes in p38 MAPK and TGF-beta signaling in differentiating MC3T3-E1 cells.
Ma GK; Chiu R; Huang Z; Pearl J; Ma T; Smith RL; Goodman SB
J Biomed Mater Res A; 2010 Jul; 94(1):234-40. PubMed ID: 20166219
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated small interfering RNA targeting tumor necrosis factor-α inhibits titanium particle-induced osteoclastogenesis and bone resorption.
Guo H; Zhang J; Hao S; Jin Q
Int J Mol Med; 2013 Aug; 32(2):296-306. PubMed ID: 23760678
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.
Kim JA; Ihn HJ; Park JY; Lim J; Hong JM; Kim SH; Kim SY; Shin HI; Park EK
Int Orthop; 2015 Jan; 39(1):173-82. PubMed ID: 25416122
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of p38 MAPK inhibitor on wear debris-induced inflammatory osteolysis through downregulating RANK/RANKL in a mouse model.
Chen D; Li Y; Guo F; Lu Z; Hei C; Li P; Jin Q
Genet Mol Res; 2015 Jan; 14(1):40-52. PubMed ID: 25729934
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by naringenin and attenuation of titanium-particle-induced osteolysis.
Wang W; Wu C; Tian B; Liu X; Zhai Z; Qu X; Jiang C; Ouyang Z; Mao Y; Tang T; Qin A; Zhu Z
Int J Mol Sci; 2014 Nov; 15(12):21913-34. PubMed ID: 25464380
[TBL] [Abstract][Full Text] [Related]
10. Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor.
Geng DC; Zhu XS; Mao HQ; Meng B; Chen L; Yang HL; Xu YZ
J Biomed Mater Res A; 2011 Dec; 99(4):516-22. PubMed ID: 21913318
[TBL] [Abstract][Full Text] [Related]
11. Gö6983 attenuates titanium particle-induced osteolysis and RANKL mediated osteoclastogenesis through the suppression of NFκB/JNK/p38 pathways.
Feng W; Li J; Liao S; Ma S; Li F; Zhong C; Li G; Wei Y; Huang H; Wei Q; Yao J; Liu Y
Biochem Biophys Res Commun; 2018 Sep; 503(1):62-70. PubMed ID: 29856998
[TBL] [Abstract][Full Text] [Related]
12. Induction of the matrix metalloproteinase-2 activation system in arteries by tensile stress. Involvement of the p38 MAP-kinase pathway.
Grabellus F; Worm K; Schmid KW
Pathol Res Pract; 2007; 203(3):135-43. PubMed ID: 17306932
[TBL] [Abstract][Full Text] [Related]
13. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
[TBL] [Abstract][Full Text] [Related]
14. Naringin inhibits titanium particles-induced up-regulation of TNF-α and IL-6 via the p38 MAPK pathway in fibroblasts from hip periprosthetic membrane.
Yang C; Liu W; Shan H; Yu X; Zhang X; Zeng B; Qian Y
Connect Tissue Res; 2021 Sep; 62(5):485-494. PubMed ID: 32500755
[TBL] [Abstract][Full Text] [Related]
15. Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis.
Rakshit DS; Ly K; Sengupta TK; Nestor BJ; Sculco TP; Ivashkiv LB; Purdue PE
J Bone Joint Surg Am; 2006 Apr; 88(4):788-99. PubMed ID: 16595469
[TBL] [Abstract][Full Text] [Related]
16. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
Wu C; Wang W; Tian B; Liu X; Qu X; Zhai Z; Li H; Liu F; Fan Q; Tang T; Qin A; Zhu Z
Biochem Pharmacol; 2015 Jan; 93(1):59-71. PubMed ID: 25449599
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells.
Mizutani A; Sugiyama I; Kuno E; Matsunaga S; Tsukagoshi N
J Bone Miner Res; 2001 Nov; 16(11):2043-9. PubMed ID: 11697800
[TBL] [Abstract][Full Text] [Related]
18. The effect of strontium ranelate on titanium particle-induced periprosthetic osteolysis regulated by WNT/β-catenin signaling in vivo and in vitro.
Wang B; Guo H; Geng T; Sun K; Zhang L; Lu Z; Jin Q
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33443286
[TBL] [Abstract][Full Text] [Related]
19. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
20. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
